[SUNETIC BIOTECH] Annual Shareholders' Meeting of Key Subsidiary SUNETIC BIOTECH INC. - Announcement of Resolutions
SUNETIC BIOTECH INC., a key subsidiary of Xinghui, held its annual shareholders' meeting on June 16,… · 2026-06-16
杏輝 News Releases
Hsing Hui Announces Board Resolution on Ex-Dividend Date and Cash Dividend Payment Date
Hsing Hui's board has resolved to distribute cash dividends, with a total amount of NT$190,196,774, … · 2026-06-16
Hin Hui Announces Key Resolutions from Annual Shareholders' Meeting
Hin Hui held its annual shareholders' meeting on June 16, 2026, approving the 2025 profit distributi… · 2026-06-16
Hsin Hui Announces Change of Spokesperson and Financial Officer
Hsin Hui Co., Ltd. announces the personnel changes of its spokesperson and financial officer due to … · 2026-06-16
Hsing Hui Announces Construction of New Automated Smart Logistics Center and Reserved Factory Space for Future Production Lines
Hsing Hui has announced the establishment of a new automated smart logistics center and reserved fac… · 2026-06-16
Hin Hui Announces Dividend Distribution by Key Subsidiary Hin Hui Tianli (Hangzhou) Pharmaceutical Co., Ltd.
Hin Hui Tianli (Hangzhou) Pharmaceutical Co., Ltd., a key subsidiary of Hin Hui, has resolved to dis… · 2026-06-16
【Xing Hui】Board of Key Subsidiary SUNETIC BIOTECH INC. Resolves on Dividend Distribution
SUNETIC BIOTECH INC., a key subsidiary of Xing Hui, has resolved to distribute a cash dividend of US… · 2026-06-16
[Sinphar] Announcement of the Company's Board Resolution to Lift Non-Compete Restrictions on Managers
Sinphar announced that it has approved the concurrent appointments of CFO Chen Chih-Hsiao and Genera… · 2026-05-05
[Sinphar] Announcement of the Company's Board Resolution to Lift Non-Compete Restrictions on Managers
Sinphar announced that it has approved the concurrent appointments of CFO Chen Chih-Hsiao and Genera… · 2026-05-05
【Apricot Blossom】Announcement by the Company in Accordance with Article 25, Paragraph 1, Subparagraph 4 of the Regulations Governing Loans of Funds and Endorsement Guarantees by Public Companies
Apricot Blossom has newly provided a bank loan endorsement guarantee of NTD 200 million for its subs… · 2026-05-05
Sinphar Announces Board Resolution Approving Q1 2026 Consolidated Financial Report
Sinphar's board of directors has approved the consolidated financial report for the first quarter of… · 2026-05-05
Sinphar Announces Board Resolution Approving Q1 2026 Consolidated Financial Report
Sinphar's board of directors has approved the consolidated financial report for the first quarter of… · 2026-05-05
【Apricot Blossom】Announcement by the Company in Accordance with Article 25, Paragraph 1, Subparagraph 4 of the Regulations Governing Loans of Funds and Endorsement Guarantees by Public Companies
Apricot Blossom has newly provided a bank loan endorsement guarantee of NTD 200 million for its subs… · 2026-05-05
[Sinphar] May 2026 Revenue Reaches NT$301 Million (+10.3% YoY)
Sinphar (TWSE: 1734), a biotech and medical company, reported May 2026 consolidated revenue of NT$30… · 2026-05-01
[Sinphar] Announcement of the Board Meeting Date for Q1 2026 Financial Reports on May 5, 2026
Sinphar Pharmaceutical announced that its board will meet on May 5 to review the company's consolida… · 2026-04-27
[Sinphar] Announcement of the Board Meeting Date for Q1 2026 Financial Reports on May 5, 2026
Sinphar Pharmaceutical announced that its board will meet on May 5 to review the company's consolida… · 2026-04-27
【Sinphar】2026-04 Monthly Revenue 291 Million (YOY +7.6%)
Sinphar announced its monthly revenue for April 2026 was 291 million TWD. This represents a 7.6% inc… · 2026-04-01
【Sinphar】2026-04 Monthly Revenue 291 Million (YOY +7.6%)
Sinphar announced its monthly revenue for April 2026 was 291 million TWD. This represents a 7.6% inc… · 2026-04-01
Hospice Announces March 2026 Revenue of NT$317 Million (Year-over-Year Increase of +5.1%)
Hospice (Stock Code: 1734), a company in the biotechnology and healthcare sector, reported its March… · 2026-03-01
Hospice Announces March 2026 Revenue of NT$317 Million (Year-over-Year Increase of +5.1%)
Hospice (Stock Code: 1734), a company in the biotechnology and healthcare sector, reported its March… · 2026-03-01
【Shin Ho】February 2026 Monthly Revenue NT$196 Million (YoY -17.4%)
Shin Ho (1734) announced its February 2026 monthly revenue as NT$196 million. This biotechnology and… · 2026-02-01
【Shin Ho】February 2026 Monthly Revenue NT$196 Million (YoY -17.4%)
Shin Ho (1734) announced its February 2026 monthly revenue as NT$196 million. This biotechnology and… · 2026-02-01